Genistein, a Potential Phytochemical against Breast Cancer Treatment-Insight into the Molecular Mechanisms

• Published in: Processes 2022-02, Vol.10 (2), p.415
• Main Authors: Sohel, Md, Biswas, Partha, Al Amin, Md, Hossain, Md. Arju, Sultana, Habiba, Dey, Dipta, Aktar, Suraiya, Setu, Arifa, Khan, Md. Sharif, Paul, Priyanka, Islam, Md. Nurul, Rahman, Md. Ataur, Kim, Bonglee, Al Mamun, Abdullah
• Format: Article
• Language: English
• Subjects: Angiogenesis; Animal models; Anticancer properties; Antitumor agents; Apoptosis; Breast cancer; Cancer therapies; Cell cycle; Cell growth; Clinical trials; Drug dosages; Drugs; Enzymes; Epidermal growth factor; ErbB-2 protein; Estrogen receptors; Estrogens; Fertility; Flavonoids; Genistein; Growth factors; Kinases; Metastases; Molecular interactions; Molecular modelling; Ovaries; Oxidative stress; Pharmaceuticals; Phosphorylation; Phytochemicals; Phytoestrogens; Prostate; Proteins; Receptors; Side effects; Tumor cell lines; Tumor suppressor genes; Tumors
• ISSN: 2227-9717; 2227-9717
• DOI: 10.3390/pr10020415

Breast cancer (BC) is one of the most common malignancies in women. Although widespread successful synthetic drugs are available, natural compounds can also be considered as significant anticancer agents for treating BC. Some natural compounds have similar effects as synthetic drugs with fewer side effects on normal cells. Therefore, we aimed to unravel and analyze several molecular mechanisms of genistein (GNT) against BC. GNT is a type of dietary phytoestrogen included in the flavonoid group with a similar structure to estrogen that might provide a strong alternative and complementary medicine to existing chemotherapeutic drugs. Previous research reported that GNT could target the estrogen receptor (ER) human epidermal growth factor receptor-2 (HER2) and several signaling molecules against multiple BC cell lines and sensitize cancer cell lines to this compound when used at an optimal inhibitory concentration. More specifically, GNT mediates the anticancer mechanism through apoptosis induction, arresting the cell cycle, inhibiting angiogenesis and metastasis, mammosphere formation, and targeting and suppressing tumor growth factors. Furthermore, it acts via upregulating tumor suppressor genes and downregulating oncogenes in vitro and animal model studies. In addition, this phytochemical synergistically reverses the resistance mechanism of standard chemotherapeutic drugs, increasing their efficacy against BC. Overall, in this review, we discuss several molecular interactions of GNT with numerous cellular targets in the BC model and show its anticancer activities alone and synergistically. We conclude that GNT can have favorable therapeutic advantages when standard drugs are not available in the pharma markets.